このアイテムのアクセス数: 45

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s41467-024-52808-2.pdf3.73 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorYajima, Hisanoen
dc.contributor.authorAnraku, Yukien
dc.contributor.authorKaku, Yuen
dc.contributor.authorTerakado Kimura, Kanakoen
dc.contributor.authorPlianchaisuk, Arnonen
dc.contributor.authorOkumura, Kahoen
dc.contributor.authorNakada-Nakura, Yoshikoen
dc.contributor.authorAtarashi, Yusukeen
dc.contributor.authorHemmi, Takuyaen
dc.contributor.authorKurod, Daisukeen
dc.contributor.authorTakahashi, Yoshimasaen
dc.contributor.authorKita, Shunsukeen
dc.contributor.authorSasaki, Jieien
dc.contributor.authorSumita, Hiromien
dc.contributor.authorThe Genotype to Phenotype Japan, (G2P-Japan) Consortiumen
dc.contributor.authorIto, Jumpeien
dc.contributor.authorMaenaka, Katsumien
dc.contributor.authorSato, Keien
dc.contributor.authorHashiguchi, Takaoen
dc.contributor.alternative矢島, 久乃ja
dc.contributor.alternative安楽, 佑樹ja
dc.contributor.alternative郭, 悠ja
dc.contributor.alternative木村(寺角), 香菜子ja
dc.contributor.alternative奥村, 佳穂ja
dc.contributor.alternative名倉, 淑子ja
dc.contributor.alternative新, 勇介ja
dc.contributor.alternative逸見, 拓矢ja
dc.contributor.alternative黒田, 大祐ja
dc.contributor.alternative高橋, 宜聖ja
dc.contributor.alternative喜多, 俊介ja
dc.contributor.alternative佐々木, 慈英ja
dc.contributor.alternative澄田, 裕美ja
dc.contributor.alternative伊東, 潤平ja
dc.contributor.alternative前仲, 勝実ja
dc.contributor.alternative佐藤, 佳ja
dc.contributor.alternative橋口, 隆生ja
dc.date.accessioned2024-11-27T05:39:03Z-
dc.date.available2024-11-27T05:39:03Z-
dc.date.issued2024-10-07-
dc.identifier.urihttp://hdl.handle.net/2433/290595-
dc.description新型コロナウイルス変異株の構造特性を解明 --流行株の変化を原子レベルで可視化 --.京都大学プレスリリース. 2024-10-08.ja
dc.description.abstractSince 2019, SARS-CoV-2 has undergone mutations, resulting in pandemic and epidemic waves. The SARS-CoV-2 spike protein, crucial for cellular entry, binds to the ACE2 receptor exclusively when its receptor-binding domain (RBD) adopts the up-conformation. However, whether ACE2 also interacts with the RBD in the down-conformation to facilitate the conformational shift to RBD-up remains unclear. Herein, we present the structures of the BA.2.86 and the JN.1 spike proteins bound to ACE2. Notably, we successfully observed the ACE2-bound down-RBD, indicating an intermediate structure before the RBD-up conformation. The wider and mobile angle of RBDs in the up-state provides space for ACE2 to interact with the down-RBD, facilitating the transition to the RBD-up state. The K356T, but not N354-linked glycan, contributes to both of infectivity and neutralizing-antibody evasion in BA.2.86. These structural insights the spike-protein dynamics would help understand the mechanisms underlying SARS-CoV-2 infection and its neutralization.en
dc.language.isoeng-
dc.publisherSpringer Natureen
dc.rights© The Author(s) 2024en
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectCryoelectron microscopyen
dc.subjectSARS-CoV-2en
dc.subjectVirus structuresen
dc.titleStructural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1en
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleNature Communicationsen
dc.identifier.volume15-
dc.relation.doi10.1038/s41467-024-52808-2-
dc.textversionpublisher-
dc.identifier.artnum8574-
dc.addressLaboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto Universityen
dc.addressLaboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido Universityen
dc.addressDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyoen
dc.addressLaboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto Universityen
dc.addressDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyoen
dc.addressDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo; Faculty of Liberal Arts, Sophia Universityen
dc.addressLaboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto Universityen
dc.addressLaboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.addressLaboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto Universityen
dc.addressResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.addressResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseases; Institute for Vaccine Research and Development (IVReD), Hokkaido Universityen
dc.addressLaboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido Universityen
dc.addressLaboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto Universityen
dc.addressResearch Administration Office, Institute for Life and Medical Sciences, Kyoto Universityen
dc.addressDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyoen
dc.addressLaboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University; Institute for Vaccine Research and Development (IVReD), Hokkaido University; Division of Pathogen Structure, International Institute for Zoonosis Control, Hokkaido University; Global Station for Biosurfaces and Drug Discovery, Hokkaido University; Kyushu Universityen
dc.addressDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo; Graduate School of Medicine, The University of Tokyo; Graduate School of Frontier Sciences, The University of Tokyo; CREST, Japan Science and Technology Agency; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University; MRC-University of Glasgow Centre for Virus Researchen
dc.addressLaboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University; CREST, Japan Science and Technology Agency; Kyoto University Immunomonitoring Center, Kyoto Universityen
dc.identifier.pmid39375326-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2024-10-08-
dcterms.accessRightsopen access-
dc.identifier.eissn2041-1723-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons